US Stocks
/
Gilead Sciences, Inc. Share Price
Gilead Sciences, Inc. Share Price

Gilead Sciences, Inc. Share Price

NASDAQ: GILD | Large Cap
$150.87
+$3.25 (2.21%) Last updated on 18 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Gilead Sciences, Inc. Stock Performance

Open
$148.78
Prev. Close
$147.61
Circuit Range
N/A
Day Range
$146.96 - $151.03
Year Range
$108.52 - $157.26
Volume
2,08,812
Average Traded
$149.34

Gilead Sciences, Inc. Share Price Today

As of 18 September 2026, Gilead Sciences, Inc.'s share price is $150.87. The stock opened at $148.78, compared to its previous close of $147.61. During today's trading session, Gilead Sciences, Inc.'s share price traded between $146.96 and $151.03, with an average price of $149.00. Over the past 52 weeks, the stock has recorded a high of $157.26 and a low of $108.52. In terms of performance, Gilead Sciences, Inc.'s share price has risen by 8.26% over the last six months and is up 35.89% on a year-on-year basis.

Gilead Sciences, Inc. Share Price Chart

$146.96$151.03
L
Show Current Price
H

Gilead Sciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$187.68B
PE Ratio (TTM)
22.06
Dividend Yield
2.13%
EPS (TTM)
$6.84
Revenue (TTM)
$29.44B
Return On Equity (TTM)
37.48%
Profit Margin
28.90%
Debt to Equity
0.52
Quarterly Earnings Growth YoY
143.58%

Gilead Sciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/A$6.95B$7.54B$6.67B$7.08B$7.77B
Net Profit-$4.17B$1.61B$1.25B$1.31B$1.96B$3.05B
Net Profit MarginN/A23.21%16.61%19.72%27.68%39.28%
Income ChangeN/A138.71%-22.37%4.95%49.05%55.71%

Gilead Sciences, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
Revenue$27.30B$27.28B$27.12B$28.75B$29.44B
Net Profit$6.22B$4.59B$5.67B$480.00M$8.51B
Net Profit Margin22.80%16.83%20.89%1.67%28.90%
Income ChangeN/A-26.23%23.37%-91.53%1672.92%

About Gilead Sciences, Inc.

Gilead Sciences Inc., headquartered in Foster City, California, is a biopharmaceutical company focused on antiviral therapies. Founded in 1987, it is best known for its treatments in HIV/AIDS (e.g., Biktarvy, Truvada) and Hepatitis C (e.g., Harvoni). Gilead has expanded into oncology and inflammation through acquisitions like Kite Pharma (CAR-T cell therapy) and Immunomedics. The company emphasizes innovation, access, and global health partnerships. Its robust pipeline includes novel antivirals and advanced immunotherapy treatments.

Gilead Sciences, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$147.87
$151.01
+1.46%
Aug 2026
$131.20
$148.84
+14.33%
Jul 2026
$127.19
$130.19
+3.13%
Jun 2026
$133.43
$126.24
-6.11%
May 2026
$130.16
$134.46
+2.76%
Apr 2026
$139.01
$130.84
-6.10%
Mar 2026
$147.87
$139.35
-6.46%
Feb 2026
$141.26
$148.97
+4.92%
Jan 2026
$122.41
$141.98
+15.65%
Dec 2025
$125.84
$122.77
-2.46%
Nov 2025
$119.82
$125.86
+5.11%
Oct 2025
$112.11
$119.74
+7.85%

GILD Share Price FAQs

What is Gilead Sciences, Inc. share price today?

chevron-up
Gilead Sciences, Inc. share price today is $150.87 as on September 18, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Gilead Sciences, Inc. stock?

chevron-up
The 52 week high of Gilead Sciences, Inc. stock is $157.26, while the 52 week low is $108.52 as of 18 Sep '26.

What is GILD's market capitalisation today?

chevron-up
GILD market capitalisation is $187.68B as of September 18, 2026, at 5:35 pm IST.

What is GILD's net income for the last quarter?

chevron-up
GILD's net income for the last quarter is 3.05B USD.

What is the 5 year returns of GILD?

chevron-up
The 5 year returns of GILD is 115.98% as on 18 Sep '26.

What is the high & low stock price of GILD today?

chevron-up
GILD stock price hit a high of $151.03 and low of $146.96 as of 18 Sep '26.

Can I buy GILD shares in India?

chevron-up
Yes. You can buy GILD in India by opening an international trading account.